Department of Genetics and Genomic Sciences

Fabry Disease: Facts for Patients and Families Free Diagnostic Studies Research Update Fabry Mailing List Building Your Family Tree Fabry Disease Support Group Fabry Disease References Overview Historical References Reviews Clinical Publications Biochemical Research Molecular Genetic Research Fabry Disease Tutorial

International Center for Fabry Disease

References

Biochemical Research

  1. Lemansky P, Bishop DF, Desnick RJ, Hasilik A, von Figura K: Synthesis and processing of a-galactosidase A in human fibroblasts. Evidence for different mutations in Fabry disease. J Biol Chem 262:2062, 1987.
  2. Kleijer WJ, Hussaarts-Odijk LM, Sacks ES, Jahoda MGJ, Niermeijer MF: Prenatal diagnosis of Fabry's disease by direct analysis of chorionic villi. Prenat Diag 7:283, 1987.
  3. Kundu SK, Diego I, Osovitz S, Marcus DM: Glycosphingolipids of human plasma. Arch Biochem Biophys 238:388, 1985.
  4. Bach G, Rosemann E, Karni A, Cohen T: Pseudodeficiency of a-galactosidase A. Clin Genet 21:59, 1982.
  5. Meuweissen SGM, Dingemans KP, Strijland A, Tager JM, Ooms BCH: Ultrastructural and biochemical liver analyses in Fabry's disease. Hepatology 2:263, 1982.
  6. Bishop DF, Desnick RJ: Affinity purification of a-galactosidase A from human spleen, placenta and plasma with elimination of pyrogen contamination. J Biol Chem 256:1307, 1981.
  7. Bishop DF, Kovac CR, Desnick RJ: Enzyme therapy XX: Further evidence for the differential in vivo fate of human splenic and plasma forms of a-galactosidase A in Fabry disease. Recovery of exogenous activity from hepatic tissue, in Callahan JW, Lowden JA (eds): Lysosomes and Lysosomal Storage Diseases. New York, NY: Raven Press, 1981, p 381.

Biochemical Sources 1961 - 1980

  1. Desnick RJ, Dean KJ, Grabowski GA, Bishop DF, Sweeley CC: Enzyme therapy XII: Enzyme therapy in Fabry's disease: Differential enzyme and substrate clearance kinetics of plasma and splenic a-galactosidase isozymes. Proc Natl Acad Sci USA 76:5326, 1979.
  2. Bishop DF, Sweeley CC: Plasma a-galactosidase A. Properties and comparisons with tissue a-galactosidases. Biochim Biophys Acta 525:399, 1978.
  3. Kusiak JW, Quirk JM, Brady RO, Mook GE: Purification and properties of the two major isozymes of a-galactosidase from human placenta. J Biol Chem 253:184, 1978.
  4. Johnson DL, Desnick RJ: Molecular pathology of Fabry's disease: Physical and kinetic properties of a-galactosidase A in cultured human endothelial cells. Biochim Biophys Acta 538:195, 1978.
  5. Rietra PJGM, Brouwer-Kelder EM, de Groot WP, Tager JM: The use of biochemical parameters for the detection of carriers of Fabry's disease. J Mol Med 1:237, 1976.
  6. Johnson DL, Del Monte MA, Cotlier E, Desnick RJ: Fabry disease: Diagnosis of hemizygotes and heterozygotes by a-galactosidase A activity in tears. Clin Chim Acta 63:81, 1975.
  7. Romeo G, Urso M, Piszcane A, Blum E, de Falco A, Ruffilli A: Residual activity of a-galactosidase A in Fabry's disease. Biochem Genet 13:615, 1975.
  8. Rietra PJGM, van den Bergh FAJTM, Tager JM: Properties of the residual a-galactosidase activity in the tissues of a Fabry hemizygote. Clin Chim Acta 62:401, 1975.
  9. Romeo G, Dimatteo G, D'urso M, Li S-C, Li Y-T: Characterization of human a-galactosidase A and B before and after neuraminidase treatment. Biochim Biophys Acta 391:349, 1975.
  10. Rietra PJGM, Molenaar JL, Hamers MN, Tager JM, Borst P: Investigation of the a-galactosidase deficiency in Fabry's disease using antibodies against the purified enzyme. Eur. J Biochem 46:89, 1974.
  11. Ho MW: Hydrolysis of ceramide trihexoside by a specific a-galactosidase from human liver. Biochem J 133:1, 1973.
  12. Beutler E, Kuhl W: Purification and properties of human a-galactosidases. J Biol Chem 247:7195, 1972.
  13. Desnick RJ, Dawson G, Desnick SJ, Sweeley CC, Krivit W: Diagnosis of glycosphingolipidoses by urinary sediment analysis. N Engl J Med 284:739, 1971.
  14. Mapes CA, Anderson RL, Sweeley CC, Desnick RJ, Krivit W: Enzyme replacement in Fabry's disease, an inborn error of metabolism. Science 169:987, 1970.
  15. Schibanoff JM, Kamoshita S, O'Brien JS: Tissue distribution of glycosphingolipids in a case of Fabry's disease. J Lipid Res 10:515, 1969.
  16. Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L: Enzymatic defect in Fabry's disease: Ceramide trihexosidase deficiency. N Engl J Med 276:1163, 1967.
  17. Lou HOC: A biochemical investigation of angiokeratoma corporis diffusum. Acta Path Microbiol Scand 68:332, 1966.
  18. Sweeley CC, Klinosky B: Fabry's disease: Classification as a sphingolipidosis and partial characterization of a novel glycolipid. J Biol Chem 238:3148, 1963.
Print Page

    ©2009 The Mount Sinai Medical Center